PFE241122P39000
- 12.75
- 0.000.00%
Pfizer Newsroom
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Extensively
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
BridgeBio Gets US Approval for Heart Drug to Compete With Pfizer
Pfizer Options Spot-On: On November 22nd, 411.31K Contracts Were Traded, With 3.36 Million Open Interest
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)
Market Climbs, Bitcoin Close to $100k | Live Stock
Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination
Pfizer Options Spot-On: On November 21st, 265.78K Contracts Were Traded, With 3.35 Million Open Interest
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Optimism Over Global Healthcare Sector Rises: Jefferies
Watching Shares Of Vaccine Stocks; Traders Circulate Article Titled "Top FDA Vaccine Official Says RFK Jr. Nomination Is a Chance for Scientist to Make the Case for Vaccines"
Express News | Live On CNBC, Josh Brown Announces Cut Pfizer Position By Half
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Pyxis Stock Craters 46% Amid Phase 1 Data, William Blair Downgrade
Pfizer Names New Head Of Research And Development
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
Sector Update: Health Care Stocks Rise Pre-Bell Thursday
The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair